Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
No To Hattatsu. 2004 Sep;36(5):391-4.

[Two cases of adult Down syndrome treated with selective serotonin re-uptake inhibitor for behavior disorders].

[Article in Japanese]

Author information

  • 1Department of Pediatrics, National Hospital Organization Fukushima Hospital, Sukagawa, Fukushima.

Abstract

Adult patients with Down syndrome show psychological symptoms and early senility. Improving their environment and dealing with their complaints and stress should first address their behavioral problems, such as self-injury, depression, aggression and outbursts. Pharmacological treatment may also be tried for behavioral disorders. Individuals with Down syndrome demonstrate neurotransmitter changes such as the loss of acetylcholine, norepinephrine, and serotonin (5-HT) with increasing age. Selective serotonin re-uptake inhibitor (SSRI) is effective for depression and panic disorders. We report here the effect of SSRI in two adult male patients with Down syndrome, 35 and 47 years of age. Self-injury in one case and aggression and outbursts in another improved after 1 week of fluvoxamine treatment, suggesting the effects of SSRI for behavioral disorders of adult Down syndrome.

PMID:
15461027
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk